Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1996-08-07
2000-02-08
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514575, 548495, 549 72, 560312, 562623, C07C31141, A61K 31215
Patent
active
060228938
ABSTRACT:
The present invention relates to:
REFERENCES:
patent: 2868691 (1959-01-01), Porush et al.
patent: 3095355 (1963-06-01), Aramson et al.
patent: 3316257 (1967-04-01), Ohnacker
patent: 4146716 (1979-03-01), Cox et al.
patent: 4196207 (1980-04-01), Webber
patent: 4435566 (1984-03-01), Ohno et al.
patent: 5017610 (1991-05-01), Imaki et al.
patent: 5455258 (1995-10-01), MacPherson et al.
Inhibitors of matrix metalloproteinases (MMP's), Beeley et al, Curr. Opin. Ther. Patents (1994) 4(1):7-16, Current Drugs Ltd. ISSN 0962-2594.
Kanazawa Hidekazu
Miyazaki Tohru
Ohno Hiroyukii
Sakaki Katsuhito
Sugiura Tsuneyuki
Gerstl Robert
Ono Pharmaceutical Co. Ltd.
LandOfFree
Hydroxamic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxamic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxamic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1681755